Natalie Boytsov

1.3k total citations · 1 hit paper
44 papers, 890 citations indexed

About

Natalie Boytsov is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Natalie Boytsov has authored 44 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Natalie Boytsov's work include Multiple Myeloma Research and Treatments (19 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Dermatology and Skin Diseases (6 papers). Natalie Boytsov is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Dermatology and Skin Diseases (6 papers). Natalie Boytsov collaborates with scholars based in United States, United Kingdom and Spain. Natalie Boytsov's co-authors include Xiang Zhang, Andre B. Araujo, Krista Schroeder, Kaleb Michaud, Theresa Hunter, Kelly Krohn, Donna McMorrow, Joseph M. Lane, Daniel H. Solomon and Stephen S. Johnston and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Bone and Joint Surgery.

In The Last Decade

Natalie Boytsov

41 papers receiving 880 citations

Hit Papers

Prevalence of rheumatoid arthritis in the United States a... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014
    2017 321 citations Theresa Hunter, Natalie Boytsov et al. Rheumatology International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natalie Boytsov United States 11 283 282 265 182 156 44 890
Axel Svedbom Sweden 19 353 1.2× 188 0.7× 347 1.3× 100 0.5× 85 0.5× 55 981
Bradley S. Stolshek United States 16 237 0.8× 139 0.5× 116 0.4× 266 1.5× 120 0.8× 44 753
Sarah Westlake United Kingdom 7 188 0.7× 402 1.4× 135 0.5× 70 0.4× 91 0.6× 8 993
Stéphanie Rouanet France 22 112 0.4× 456 1.6× 230 0.9× 102 0.6× 130 0.8× 57 1.4k
Asgar Ali Kalla South Africa 16 195 0.7× 317 1.1× 163 0.6× 68 0.4× 75 0.5× 42 823
Alessandro Giollo Italy 21 280 1.0× 557 2.0× 101 0.4× 240 1.3× 135 0.9× 90 1.5k
Alfred Cividino Canada 19 257 0.9× 833 3.0× 89 0.3× 189 1.0× 270 1.7× 33 1.5k
Ricardo J O Ferreira Portugal 15 106 0.4× 634 2.2× 94 0.4× 53 0.3× 253 1.6× 67 1.0k
Jorge Arellano United States 18 184 0.7× 63 0.2× 277 1.0× 354 1.9× 43 0.3× 40 880
Ogo Egbuna United States 18 322 1.1× 49 0.2× 230 0.9× 371 2.0× 36 0.2× 37 1.3k

Countries citing papers authored by Natalie Boytsov

Since Specialization
Citations

This map shows the geographic impact of Natalie Boytsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Boytsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Boytsov more than expected).

Fields of papers citing papers by Natalie Boytsov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Boytsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Boytsov. The network helps show where Natalie Boytsov may publish in the future.

Co-authorship network of co-authors of Natalie Boytsov

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Boytsov. A scholar is included among the top collaborators of Natalie Boytsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Boytsov. Natalie Boytsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richter, Joshua, Ajay K. Nooka, Paula Rodríguez‐Otero, et al.. (2025). Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta‐Analysis. American Journal of Hematology. 100(6). 998–1009. 1 indexed citations
2.
Boytsov, Natalie, et al.. (2025). Impact of social determinants of health on treatment patterns and outcomes in multiple myeloma. Future Oncology. 21(13). 1663–1673.
3.
Gay, Francesca, Elena Zamagni, Craig E. Cole, et al.. (2025). Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review. Frontiers in Oncology. 15. 1550644–1550644.
4.
Pandey, Arvind, et al.. (2024). CO75 Clinical Outcomes Associated with Anti-CD38 Retreatment in Relapsed/Refractory Multiple Myeloma: A Review of the Literature. Value in Health. 27(6). S31–S31. 4 indexed citations
5.
Yang, Joseph Yuan‐Mou, Natalie Boytsov, Josh J. Carlson, & Douglas Barthold. (2023). Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis. Journal of Managed Care & Specialty Pharmacy. 29(8). 917–926. 5 indexed citations
6.
7.
Hultcrantz, Malin, David Kleinman, Ravi Vij, et al.. (2023). Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update.. Journal of Clinical Oncology. 41(16_suppl). e20046–e20046. 1 indexed citations
8.
9.
Boytsov, Natalie, et al.. (2022). Prescription Market Share and Treatment Patterns in Atopic Dermatitis: A Retrospective Observational Study Using US Insurance Claims. Advances in Therapy. 39(5). 2052–2064. 8 indexed citations
10.
McGuiness, Catherine B., et al.. (2021). Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials. Rheumatology and Therapy. 8(2). 793–802. 2 indexed citations
11.
Pierce, Evangeline, et al.. (2021). A Qualitative Analysis of Provider Notes of Atopic Dermatitis-Related Visits Using Natural Language Processing Methods. Dermatology and Therapy. 11(4). 1305–1318. 9 indexed citations
12.
Boytsov, Natalie, et al.. (2021). The current treatment landscape in adult atopic dermatitis in the United States: results from a cross-sectional real-world study. Journal of Dermatological Treatment. 33(3). 1707–1717. 6 indexed citations
13.
14.
Boytsov, Natalie, Xiang Zhang, Kristin Evans, & Barbara H. Johnson. (2019). Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis. PharmacoEconomics - Open. 4(1). 105–117. 16 indexed citations
15.
Kern, David M., Lawrence Chang, Kalyani Sonawane, et al.. (2018). Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population. Rheumatology and Therapy. 5(2). 355–369. 24 indexed citations
16.
Katz, Patricia, Amanda Quebe, Hiren Patel, et al.. (2018). FRI0080 The role of pain in rheumatoid arthritis (RA) patients' assessments of their health. Annals of the Rheumatic Diseases. 77. 586–586.
17.
Boytsov, Natalie, C. Gaich, Xiang Zhang, et al.. (2018). Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study. Rheumatology and Therapy. 5(1). 215–229. 4 indexed citations
18.
Hunter, Theresa, Natalie Boytsov, Xiang Zhang, et al.. (2017). Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatology International. 37(9). 1551–1557. 321 indexed citations breakdown →
19.
Keshishian, Allison, Natalie Boytsov, Russel Burge, et al.. (2017). Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population. Osteoporosis International. 28(8). 2485–2494. 22 indexed citations
20.
Grabner, Michael, Natalie Boytsov, Qing Huang, et al.. (2017). Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis. Arthritis Research & Therapy. 19(1). 92–92. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Svedbom Breakdown of academic impact, for papers by Bradley S. Stolshek Breakdown of academic impact, for papers by Sarah Westlake Breakdown of academic impact, for papers by Stéphanie Rouanet Breakdown of academic impact, for papers by Asgar Ali Kalla Breakdown of academic impact, for papers by Alessandro Giollo Breakdown of academic impact, for papers by Alfred Cividino Breakdown of academic impact, for papers by Ricardo J O Ferreira Breakdown of academic impact, for papers by Jorge Arellano Breakdown of academic impact, for papers by Ogo Egbuna
Rankless by CCL
2026